Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03365128
Other study ID # Blakeman2017
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 1, 2025
Est. completion date January 1, 2026

Study information

Verified date May 2024
Source University of Cincinnati
Contact Thomas C Blakeman, MSc
Phone 513-558-0514
Email blakemtc@ucmain.uc.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a study to validate the efficacy of using a small portable oxygen source to mitigate altitude-induced hypoxia.


Description:

The purpose of this study is to validate the efficacy of using a small portable oxygen source to mitigate altitude-induced hypoxic events. To do so, the invesitgators propose the following aims: 1. Determine the ability of a portable oxygen storage device to reverse hypobaric hypoxemia in volunteers at altitude. 2. Determine the duration of time that a single portable oxygen container can maintain normoxia in normal volunteers at altitude. 3. Determine the optimum dose and timing of oxygen use to reverse hypobaric hypoxemia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date January 1, 2026
Est. primary completion date September 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Altitude chamber qualified - Previous agreement to be approached regarding altitude chamber research Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Cincinnati

Outcome

Type Measure Description Time frame Safety issue
Primary Elapsed time during which oxygen saturation by pulse oximetry (SpO2) remains above 90% I Elapsed time during which subject's SpO2 remains above 90% after initially reaching or exceeding 94% following exposure to a simulated altitude of 14,000 and after receiving pulse-dosed oxygen 15 minutes
Secondary Amount of oxygen needed to return SpO2 to sea level value I Amount of oxygen needed to return subject's SpO2 value to 94% (or higher) after exposure to a simulated altitude of 14,000 feet 15 minutes
Secondary Amount of oxygen needed to return SpO2 to sea level value II Amount of oxygen needed to return subject's SpO2 value to 94% (or higher) after (i) reaching SpO2 value of 82-84% or (ii) attaining 85% of maximum predicted heart rate. This is following exercise on a stationary bicycle at a simulated altitude of 10,000 feet 15 minutes
Secondary Elapsed time during which SpO2 remains above 90% II Elapsed time during which subject's SpO2 remains above 90% after initially following exposure to a simulated altitude of 14,000 and after initially (i) reaching SpO2 value of 82-84% or (ii) attaining 85% of maximum predicted heart rate. This is following exercise on a stationary bicycle at a simulated altitude of 10,000 feet and after receiving pulse-dosed oxygen. 15 minutes
See also
  Status Clinical Trial Phase
Completed NCT01477450 - Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects N/A